Literature DB >> 33822915

Histological Disease Activity Measured by the Nancy Index Is Associated with Long-term Outcomes in Patients with Ulcerative Colitis.

Ferdinando D'Amico1,2,3, Lucas Guillo3,4, Cedric Baumann5, Silvio Danese1,2, Laurent Peyrin-Biroulet3.   

Abstract

BACKGROUND AND AIMS: Histological healing might be the ultimate therapeutic goal in ulcerative colitis [UC]. Our aim was to investigate the association between histological disease activity as measured by a validated index and long-term outcomes in patients with UC.
METHODS: An observational retrospective cohort study was conducted at the Nancy University Hospital between January 2014 and March 2020. All consecutive patients with confirmed UC, undergoing colonoscopy with biopsies and available histological reports, were eligible for inclusion.
RESULTS: A total of 156 patients were included [53% female with a mean age of 41.3 ± 15.4 years]. About a quarter of patients were in histological remission [Nancy index = 0] at baseline [n = 42, 26.9%]. Median follow-up was 30.5 months [range 0-75]. Sixteen patients with histological disease activity at baseline [Nancy index ≥ 1] underwent surgery during follow-up compared with no subject in the histological remission group [14.0% vs 0.0%, respectively, p = 0.01]. Similarly, a higher rate of hospitalisation was found in patients with histological disease activity at baseline than in the histological remission group [36.0% vs 7.1%, respectively, p = 0.001]. The Kaplan-Meier analysis showed that patients with histological disease activity at baseline had a 5-year surgery rate of 16.7% [logrank p = 0.01] and a 5-year hospitalisation rate of 19.7% [logrank p = 0.0002]. In the multivariate regression model, Nancy index > 0 was independently associated with the risk of hospitalisation [hazard ratio 8.88, confidence interval 95% 2.5-31.1, p = 0.0007].
CONCLUSIONS: UC patients with histological disease activity, as measured by the Nancy index, have a greater risk of surgery and hospitalisation.
© The Author(s) 2021. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Histology; hospitalisations; long-term outcomes; surgery; ulcerative colitis

Mesh:

Year:  2021        PMID: 33822915     DOI: 10.1093/ecco-jcc/jjab063

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  6 in total

Review 1.  Histological Scores in Patients with Inflammatory Bowel Diseases: The State of the Art.

Authors:  Edoardo Vespa; Ferdinando D'Amico; Mauro Sollai; Mariangela Allocca; Federica Furfaro; Alessandra Zilli; Arianna Dal Buono; Roberto Gabbiadini; Silvio Danese; Gionata Fiorino
Journal:  J Clin Med       Date:  2022-02-11       Impact factor: 4.241

2.  Ulcerative colitis: Impact of early disease clearance on long-term outcomes - A multicenter cohort study.

Authors:  Ferdinando D'Amico; Gionata Fiorino; Virginia Solitano; Eugenia Massarini; Lucas Guillo; Mariangela Allocca; Federica Furfaro; Alessandra Zilli; Stefanos Bonovas; Fernando Magro; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  United European Gastroenterol J       Date:  2022-09-15       Impact factor: 6.866

3.  Development and validation of novel models for the prediction of intravenous corticosteroid resistance in acute severe ulcerative colitis using logistic regression and machine learning.

Authors:  Si Yu; Hui Li; Yue Li; Hui Xu; Bei Tan; Bo-Wen Tian; Yi-Min Dai; Feng Tian; Jia-Ming Qian
Journal:  Gastroenterol Rep (Oxf)       Date:  2022-09-30

Review 4.  Histopathological assessment of the microscopic activity in inflammatory bowel diseases: What are we looking for?

Authors:  Ondrej Fabian; Lukas Bajer
Journal:  World J Gastroenterol       Date:  2022-09-28       Impact factor: 5.374

Review 5.  Endoscopic and Histologic Predictors of Outcomes in Pediatric Ulcerative Colitis-Caveat Emptor.

Authors:  Lorraine Stallard; Séamus Hussey
Journal:  Front Pediatr       Date:  2021-06-23       Impact factor: 3.418

6.  Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?

Authors:  Ferdinando D'Amico; Alessandra Zilli; Gionata Fiorino
Journal:  United European Gastroenterol J       Date:  2022-01-22       Impact factor: 4.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.